相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
Fatemeh K. Dermani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Selection and characterization of novel DNA aptamer against colorectal carcinoma Caco-2 cells
Yasen Maimaitiyiming et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2019)
Rapid identification of specific DNA aptamers precisely targeting CD33 positive leukemia cells through a paired cell-based approach
Chang Yang et al.
BIOMATERIALS SCIENCE (2019)
Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray
Irawan Cosphiadi et al.
CLINICAL BREAST CANCER (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
John D. Hainsworth et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers
Christina Kratschmer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Selection of Metastatic Breast Cancer Cell-Specific Aptamers for the Capture of CTCs with a Metastatic Phenotype by Cell-SELEX
Wan-Ming Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Overcoming Resistance of Human Non-Hodgkin's Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors
Antoni Xavier Torres-Collad et al.
CANCERS (2018)
Application of aptamers for in vivo molecular imaging and theranostics
Alix Bouvier-Mueller et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
SELEX methods on the road to protein targeting with nucleic acid aptamers
Payam Bayat et al.
BIOCHIMIE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles
Yijuan Zhang et al.
ACS NANO (2017)
Human genomics projects and precision medicine
F. Carrasco-Ramiro et al.
GENE THERAPY (2017)
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes
Carlos A. Ramos et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Dimerization of Cell-Adhesion Molecules Can Increase Their Binding Strength
Wenmao Huang et al.
LANGMUIR (2017)
RITUXIMAB TREATMENT OF MYASTHENIA GRAVIS: A SYSTEMATIC REVIEW
Rup Tandan et al.
MUSCLE & NERVE (2017)
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2017)
Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is Hope
Jonathan M. Lehman et al.
CURRENT ONCOLOGY REPORTS (2017)
Oligonucleotide Hybridization Combined with Competitive Antibody Binding for the Truncation of a High-Affinity Aptamer
Cong Quang Vu et al.
ACS COMBINATORIAL SCIENCE (2017)
Aptamer-Based Therapeutic Approaches to Target Cancer Stem Cells
Gang Zhou et al.
THERANOSTICS (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform
Priya Gopinathan et al.
BIOMICROFLUIDICS (2017)
Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects
Hongyan Jia et al.
DRUG RESISTANCE UPDATES (2017)
TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis
Kirill V. Korneev et al.
CYTOKINE (2017)
Aptamers: new arrows to target dendritic cells
A. Ganji et al.
JOURNAL OF DRUG TARGETING (2016)
Self-Assembled DNA Nanocentipede as Multivalent Drug Carrier for Targeted Delivery
Wenshan Li et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles
Xiaozhou Fan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Application of aptamers in diagnostics, drug-delivery and imaging
Chetan Chandola et al.
JOURNAL OF BIOSCIENCES (2016)
An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies
Kyun Heo et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
A. Michael Lincoff et al.
LANCET (2016)
Methods for Improving Aptamer Binding Affinity
Hijiri Hasegawa et al.
MOLECULES (2016)
Improved Synthesis and In Vitro Evaluation of an Aptamer Ribosomal Toxin Conjugate
Linsley Kelly et al.
NUCLEIC ACID THERAPEUTICS (2016)
MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
Mario Martinez Soldevilla et al.
ONCOTARGET (2016)
Aptamers: A Feasible Technology in Cancer Immunotherapy
M. M. Soldevilla et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors A Review
Claire F. Friedman et al.
JAMA ONCOLOGY (2016)
Therapeutic aptamers: developmental potential as anticancer drugs
Ji Won Lee et al.
BMB REPORTS (2015)
Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase
D. Di Gioia et al.
BRITISH JOURNAL OF CANCER (2015)
Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer therapeutics
Axel Vater et al.
DRUG DISCOVERY TODAY (2015)
Active Immunotherapy of Cancer
Thinle Chodon et al.
IMMUNOLOGICAL INVESTIGATIONS (2015)
Cancer immunotherapy via nucleic acid aptamers
Mostafa Khedri et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shabnam Shalapour et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Selection of LNA-containing DNA aptamers against recombinant human CD73
Ida C. Elle et al.
MOLECULAR BIOSYSTEMS (2015)
Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
Abhisek Swaika et al.
MOLECULAR IMMUNOLOGY (2015)
Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
Aaron Prodeus et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
A. Roesch
ONCOGENE (2015)
Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer
Weihong Liu et al.
TUMOR BIOLOGY (2015)
Just in Time-Selection: A Rapid Semiautomated SELEX of DNA Aptamers Using Magnetic Separation and BEAMing
Tim Huenniger et al.
ANALYTICAL CHEMISTRY (2014)
Mini-Array of Multiple Tumor-associated Antigens (TAAs) in the Immunodiagnosis of Esophageal Cancer
Jie-Jie Qin et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Improved Ligand Binding by Antibody-Aptamer Pincers
Sungmuk Kang et al.
BIOCONJUGATE CHEMISTRY (2014)
Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans
Lucas T. van Eijk et al.
BLOOD (2014)
Aptamers as Drug Delivery Vehicles
Sven Kruspe et al.
CHEMMEDCHEM (2014)
Th1 cytokine-based immunotherapy for cancer
Hong-Mei Xu
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2014)
Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor
Shashi Gupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells
Andreas Herrmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Resistance to Arsenic Therapy in Acute Promyelocytic Leukemia
Hong-Hu Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Radiogenomics : Using Genetics to Identify Cancer Patients at Risk for Development of Adverse Effects Following Radiotherapy
Sarah L. Kerns et al.
CANCER DISCOVERY (2014)
Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy
Qiaoling Liu et al.
NPG ASIA MATERIALS (2014)
Specific and Sensitive Tumor Imaging Using Biostable Oligonucleotide Aptamer Probes
Zihua Zeng et al.
THERANOSTICS (2014)
Aptamers as Both Drugs and Drug-Carriers
Md. Ashrafuzzaman
BIOMED RESEARCH INTERNATIONAL (2014)
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Eric R. Lutz et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Identification and expression of troponin T, a new marker on the surface of cultured tumor endothelial cells by aptamer ligand
Mst. Naznin Ara et al.
CANCER MEDICINE (2014)
A Cancer Cell-Activatable Aptamer-Reporter System for One-Step Assay of Circulating Tumor Cells
Zihua Zeng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture
Yanling Song et al.
ANALYTICAL CHEMISTRY (2013)
Level of agreement among Latin American glaucoma subspecialists on the diagnosis and treatment of glaucoma: results of an online survey
Daniel E. Grigera et al.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA (2013)
Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer
Wenjin Xu et al.
BIOMATERIALS (2013)
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer
Parag Parekh et al.
BIOMATERIALS (2013)
Cancer Research Advocacy: Past, Present, and Future
Jane Perlmutter et al.
CANCER RESEARCH (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics
Guizhi Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Circulating Tumor Cells
Vicki Plaks et al.
SCIENCE (2013)
Update on current and future novel therapies for dry age-related macular degeneration
Ella Leung et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2013)
Dimeric DNA Aptamer Complexes for High-capacity-targeted Drug Delivery Using pH-sensitive Covalent Linkages
Olcay Boyacioglu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
CD28 Aptamers as Powerful Immune Response Modulators
Fernando Pastor et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
In vivo SELEX for Identification of Brain-penetrating Aptamers
Congsheng Cheng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Update on the challenges and recent advances in cancer immunotherapy
Gianfranco Baronzio et al.
IMMUNOTARGETS AND THERAPY (2013)
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application
Sophia N. Karagiannis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Targeted immunotherapy of cancer with CAR T cells: achievements and challenges
Grazyna Lipowska-Bhalla et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells
Jiajun Cui et al.
CANCER RESEARCH (2012)
Self-Assembled Aptamer-Based Drug Carriers for Bispecific Cytotoxicity to Cancer Cells
Guizhi Zhu et al.
CHEMISTRY-AN ASIAN JOURNAL (2012)
Recent advances in the application of antibodies as therapeutics
Roberta E. Burden et al.
FUTURE MEDICINAL CHEMISTRY (2012)
A nanoscale drug delivery carrier using nucleic acid aptamers for extended release of therapeutic
Padma Sundaram et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Development of a Novel DNA Aptamer Ligand Targeting to Primary Cultured Tumor Endothelial Cells by a Cell-Based SELEX Method
Mst. Naznin Ara et al.
PLOS ONE (2012)
Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia
Matthew Gissel et al.
THROMBOSIS RESEARCH (2012)
The circular dichroism and differential scanning calorimetry study of the properties of DNA aptamer dimers
Slavomira Ponikova et al.
BIOPHYSICAL CHEMISTRY (2011)
The Diagnosis and Treatment Decisions of Cancer Patients in Rural Western Australia
Ruth McConigley et al.
CANCER NURSING (2011)
The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse
Anna Merlos-Suarez et al.
CELL STEM CELL (2011)
Chimeric aptamers in cancer cell-targeted drug delivery
Jagat R. Kanwar et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
Ronak Savla et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Where Are All the Aptamers?
Geoffrey S. Baird
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
US Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab
Steven J. Lemery et al.
CLINICAL CANCER RESEARCH (2010)
Antibody-aptamer functionalized fibre-optic biosensor for specific detection of Listeria monocytogenes from food
S. H. Ohk et al.
JOURNAL OF APPLIED MICROBIOLOGY (2010)
Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency
Maximilian C. R. Buff et al.
NUCLEIC ACIDS RESEARCH (2010)
Strategies and challenges for the next generation of therapeutic antibodies
Alain Beck et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment
Jaume Capdevila et al.
CANCER TREATMENT REVIEWS (2009)
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Paula J. Bates et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediated ex vivo platelet function in acute myocardial infarction
Alexander O. Spiel et al.
PLATELETS (2009)
Active and passive immunotherapy for Neurodegenerative disorders
David L. Brody et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
The history of cancer research: Introducing an AACR Centennial series
I. Bernard Weinstein et al.
CANCER RESEARCH (2008)
Cell-specific internalization study of an aptamer from whole cell selection
Zeyu Xiao et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
FDA drug approval summary: Alemtuzumab as single-agent treatment for B-Cell chronic lymphocytic leukemia
Suzanne Demko et al.
ONCOLOGIST (2008)
Improvement of aptamer affinity by dimerization
Hijiri Hasegawa et al.
SENSORS (2008)
Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: Looking for the grail
L. Juillerat-Jeanneret et al.
MEDICINAL RESEARCH REVIEWS (2007)
Targeted inhibition of αvβ3 integrin with an RNA aptamer impairs endothelial cell growth and survival
J Mi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Automated selection of aptamers against protein targets translated in vitro:: from gene to aptamer -: art. no. e108
JC Cox et al.
NUCLEIC ACIDS RESEARCH (2002)
分享论文
